CA2817619A1
(en)
|
2001-06-08 |
2002-12-08 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
US7329405B2
(en)
|
2001-08-23 |
2008-02-12 |
Genmab A/S |
Human antibodies specific for interleukin 15 (IL-15)
|
EP1425389B1
(en)
|
2001-08-23 |
2011-11-02 |
Genmab A/S |
Human antibodies specific for interleukin 15 (il-15)
|
US7247304B2
(en)
*
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
GB0208817D0
(en)
*
|
2002-04-17 |
2002-05-29 |
European Molecular Biology Lab Embl |
Method for producing monoclonal antibodies
|
RS20050724A
(en)
*
|
2003-02-26 |
2007-11-15 |
Genmab A/S., |
Human antibodies specific for interleukin 15(il-15)
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
US20050123542A1
(en)
*
|
2003-11-06 |
2005-06-09 |
Genmab A/S |
Methods for treating disorders involving monocytes
|
SG156672A1
(en)
*
|
2004-10-22 |
2009-11-26 |
Amgen Inc |
Methods for refolding of recombinant antibodies
|
EP1830875A2
(en)
*
|
2004-12-13 |
2007-09-12 |
Cytos Biotechnology AG |
Il-15 antigen arrays and uses thereof
|
NZ591701A
(en)
|
2005-05-16 |
2012-11-30 |
Abbott Biotech Ltd |
Use of tnf inhibitor for treatment of erosive polyarthritis
|
BRPI0611901A2
(pt)
|
2005-06-14 |
2012-08-28 |
Amgen, Inc |
composição, liofilizado, kit, e, processo para preparar uma composição
|
US20070190057A1
(en)
*
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
US9399061B2
(en)
*
|
2006-04-10 |
2016-07-26 |
Abbvie Biotechnology Ltd |
Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis
|
US9605064B2
(en)
|
2006-04-10 |
2017-03-28 |
Abbvie Biotechnology Ltd |
Methods and compositions for treatment of skin disorders
|
US20080131374A1
(en)
*
|
2006-04-19 |
2008-06-05 |
Medich John R |
Uses and compositions for treatment of rheumatoid arthritis
|
EP2468776A3
(en)
|
2007-02-09 |
2012-11-14 |
Genentech, Inc. |
Anti-Robo4 antibodies and uses therefor
|
EP2171451A4
(en)
|
2007-06-11 |
2011-12-07 |
Abbott Biotech Ltd |
METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
|
EP2197421A1
(en)
*
|
2007-08-31 |
2010-06-23 |
Amgen, Inc |
Solid-state protein formulation
|
MX2010002683A
(es)
*
|
2007-09-14 |
2010-03-26 |
Amgen Inc |
Poblaciones de anticuerpos homogeneos.
|
ES2750254T3
(es)
|
2007-09-27 |
2020-03-25 |
Amgen Inc |
Formulaciones farmacéuticas
|
EP3381445B1
(en)
|
2007-11-15 |
2023-10-25 |
Amgen Inc. |
Aqueous formulation of antibody stablised by antioxidants for parenteral administration
|
AR069501A1
(es)
|
2007-11-30 |
2010-01-27 |
Genentech Inc |
Anticuerpos anti- vegf (factor de crecimiento endotelial vascular)
|
EP2098536A1
(en)
|
2008-03-05 |
2009-09-09 |
4-Antibody AG |
Isolation and identification of antigen- or ligand-specific binding proteins
|
MX2010010503A
(es)
*
|
2008-03-24 |
2010-11-09 |
Abbott Biotech Ltd |
Metodos y composiciones para tratar perdida osea.
|
CU23716A1
(es)
|
2008-09-30 |
2011-10-05 |
Ct Ingenieria Genetica Biotech |
Péptido antagonista de la actividad de la interleucina-15
|
UA109633C2
(uk)
|
2008-12-09 |
2015-09-25 |
|
Антитіло людини проти тканинного фактора
|
TW201106972A
(en)
|
2009-07-27 |
2011-03-01 |
Genentech Inc |
Combination treatments
|
JP5887270B2
(ja)
|
2009-09-02 |
2016-03-16 |
ジェネンテック, インコーポレイテッド |
突然変異体smoothenedおよびその使用方法
|
AU2010310457B2
(en)
|
2009-10-23 |
2015-07-02 |
Amgen Inc. |
Vial adapter and system
|
EP2509626B1
(en)
|
2009-12-11 |
2016-02-10 |
F.Hoffmann-La Roche Ag |
Anti-vegf-c antibodies and methods using same
|
SG2014011340A
(en)
|
2009-12-21 |
2014-07-30 |
Genentech Inc |
Antibody formulation
|
SG194370A1
(en)
|
2010-06-07 |
2013-11-29 |
Amgen Inc |
Drug delivery device
|
LT2580243T
(lt)
|
2010-06-09 |
2020-01-27 |
Genmab A/S |
Antikūnai prieš žmogaus cd38
|
CA2802782C
(en)
|
2010-06-15 |
2018-03-13 |
Genmab A/S |
Human antibody drug conjugates against tissue factor
|
DK2625197T3
(da)
|
2010-10-05 |
2016-10-03 |
Genentech Inc |
Smoothened-mutant og fremgangsmåder til anvendelse af samme
|
US9480624B2
(en)
|
2011-03-31 |
2016-11-01 |
Amgen Inc. |
Vial adapter and system
|
PT2699293T
(pt)
|
2011-04-20 |
2019-05-21 |
Amgen Inc |
Aparelho de autoinjeção
|
CN102250243B
(zh)
*
|
2011-07-01 |
2013-08-28 |
华绍炳 |
抗白细胞介素-15抗体
|
CN103797028B
(zh)
*
|
2011-07-18 |
2017-08-25 |
Iba 股份有限公司 |
使靶细胞可逆染色的方法
|
AU2012322796B2
(en)
|
2011-10-14 |
2017-03-16 |
Amgen Inc. |
Injector and method of assembly
|
JP2015535464A
(ja)
|
2012-11-21 |
2015-12-14 |
アムジエン・インコーポレーテツド |
薬剤送達装置
|
ES2730011T3
(es)
*
|
2013-02-20 |
2019-11-07 |
Innate Pharma |
Un compuesto que se une específicamente a KIR3DL2 para el uso en el tratamiento de linfoma de células T periférico
|
US10653779B2
(en)
|
2013-03-13 |
2020-05-19 |
Genentech, Inc. |
Formulations with reduced oxidation
|
MX365567B
(es)
|
2013-03-13 |
2019-06-07 |
Genentech Inc |
Formulaciones de anticuerpo.
|
US20140314778A1
(en)
|
2013-03-13 |
2014-10-23 |
Genentech, Inc. |
Formulations with reduced oxidation
|
CA2904169C
(en)
|
2013-03-13 |
2021-12-07 |
Genentech, Inc. |
Formulations with reduced oxidation
|
WO2014160495A1
(en)
|
2013-03-13 |
2014-10-02 |
Genentech, Inc. |
Formulations with reduced oxidation
|
CN105121628B
(zh)
|
2013-03-15 |
2020-03-24 |
豪夫迈·罗氏有限公司 |
具有抗氧化剂的细胞培养组合物和多肽生产方法
|
EP2968760B1
(en)
|
2013-03-15 |
2024-01-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
TWI639449B
(zh)
|
2013-03-15 |
2018-11-01 |
美商安美基公司 |
用於注射器之匣盒
|
LT2976117T
(lt)
|
2013-03-22 |
2021-02-25 |
Amgen Inc. |
Purkštuvas ir surinkimo būdas
|
MA38960A1
(fr)
|
2013-09-27 |
2017-10-31 |
Genentech Inc |
Formulations d'anticorps anti-pdl1
|
EP3501575B1
(en)
|
2013-10-24 |
2021-12-01 |
Amgen Inc. |
Drug delivery system with temperature-sensitive-control
|
EP3789064A1
(en)
|
2013-10-24 |
2021-03-10 |
Amgen, Inc |
Injector and method of assembly
|
EP3083686B2
(en)
|
2013-12-17 |
2023-03-22 |
F. Hoffmann-La Roche AG |
Methods of treating cancers using pd-1 axis binding antagonists and taxanes
|
EP3527587A1
(en)
|
2013-12-17 |
2019-08-21 |
F. Hoffmann-La Roche AG |
Combination therapy comprising ox40 binding agonists and pd-l1 binding antagonists
|
WO2015095410A1
(en)
|
2013-12-17 |
2015-06-25 |
Genentech, Inc. |
Methods of treating cancer using pd-1 axis binding antagonists and an anti-cd20 antibody
|
WO2015120075A2
(en)
|
2014-02-04 |
2015-08-13 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
MX2016012779A
(es)
|
2014-03-31 |
2017-04-27 |
Genentech Inc |
Terapia de combinacion con agentes antiangiogénesis y agonistas de unión a ox40.
|
CA2945026C
(en)
|
2014-05-07 |
2023-10-10 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
CA2948003C
(en)
|
2014-06-03 |
2023-06-27 |
Amgen Inc. |
Drug delivery system and method of use
|
EP2963057A1
(en)
|
2014-07-02 |
2016-01-06 |
Calypso Biotech SA |
Antibodies to IL-15
|
JP7072384B2
(ja)
|
2014-09-15 |
2022-05-20 |
ジェネンテック, インコーポレイテッド |
抗体製剤
|
MX2021014323A
(es)
|
2014-10-14 |
2023-02-02 |
Amgen Inc |
Dispositivo de inyección de fármaco con indicadores visuales y audibles.
|
MX2017005243A
(es)
|
2014-10-23 |
2017-08-18 |
Amgen Inc |
Reducción de la viscosidad de formulaciones farmacéuticas.
|
SG10201807625PA
(en)
|
2014-11-17 |
2018-10-30 |
Genentech Inc |
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
|
ES2785311T3
(es)
|
2014-12-19 |
2020-10-06 |
Amgen Inc |
Dispositivo de administración de fármacos con botón móvil o campo de interfaz de usuario
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
EP3253784B1
(en)
|
2015-02-04 |
2020-05-06 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
CA2976935C
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
EP3261690B1
(en)
|
2015-02-27 |
2021-12-15 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
CN107771076A
(zh)
|
2015-06-17 |
2018-03-06 |
豪夫迈·罗氏有限公司 |
使用pd‑1轴结合拮抗剂和紫杉烷治疗局部晚期或转移性乳腺癌的方法
|
JOP20200312A1
(ar)
|
2015-06-26 |
2017-06-16 |
Novartis Ag |
الأجسام المضادة للعامل xi وطرق الاستخدام
|
TW202330904A
(zh)
|
2015-08-04 |
2023-08-01 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
LT3334747T
(lt)
|
2015-08-13 |
2023-12-27 |
Amgen Inc. |
Įkrautas giluminis antigeną surišančio baltymo filtravimas
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
BR112018013071A2
(pt)
|
2015-12-30 |
2018-12-11 |
Genentech Inc |
uso de derivados de triptofano para formulações de proteínas
|
CA3007419A1
(en)
|
2015-12-30 |
2017-07-06 |
Genentech, Inc. |
Formulations with reduced degradation of polysorbate
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
IL259588B2
(en)
|
2016-01-08 |
2023-09-01 |
Hoffmann La Roche |
Methods for the treatment of cea-positive cancer using pd-1 spindle-binding antagonists and bispecific antibodies against anti-cea and anti-cd3
|
EP3411396A1
(en)
|
2016-02-04 |
2018-12-12 |
Curis, Inc. |
Mutant smoothened and methods of using the same
|
TWI759287B
(zh)
|
2016-03-15 |
2022-04-01 |
日商中外製藥股份有限公司 |
使用pd-1軸結合拮抗劑和抗gpc3抗體治療癌症的方法
|
WO2017160799A1
(en)
|
2016-03-15 |
2017-09-21 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
WO2017197222A1
(en)
|
2016-05-13 |
2017-11-16 |
Amgen Inc. |
Vial sleeve assembly
|
EP3458988B1
(en)
|
2016-05-16 |
2023-10-18 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
TW201802121A
(zh)
|
2016-05-25 |
2018-01-16 |
諾華公司 |
抗因子XI/XIa抗體之逆轉結合劑及其用途
|
EP3465124A1
(en)
|
2016-06-03 |
2019-04-10 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
US20180002417A1
(en)
*
|
2016-06-15 |
2018-01-04 |
Celimmune Llc |
Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
|
US11285266B2
(en)
|
2016-07-01 |
2022-03-29 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
CN109476748B
(zh)
|
2016-08-08 |
2023-05-23 |
豪夫迈·罗氏有限公司 |
用于癌症的治疗和诊断方法
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
WO2018067987A1
(en)
|
2016-10-06 |
2018-04-12 |
Amgen Inc. |
Reduced viscosity protein pharmaceutical formulations
|
AU2017345490B2
(en)
*
|
2016-10-21 |
2022-07-07 |
Amgen Inc. |
Pharmaceutical formulations and methods of making the same
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
PE20191497A1
(es)
*
|
2016-12-21 |
2019-10-21 |
Cephalon Inc |
Anticuerpos que se unen especificamente a il-15 humana y usos de estos
|
CA3048156A1
(en)
|
2016-12-23 |
2018-06-28 |
Novartis Ag |
Factor xi antibodies and methods of use
|
JP2020503976A
(ja)
|
2017-01-17 |
2020-02-06 |
アムジエン・インコーポレーテツド |
注入デバイスならびに関連する使用および組立方法
|
JP7280189B2
(ja)
|
2017-02-17 |
2023-05-23 |
アムジエン・インコーポレーテツド |
薬物送達装置用の挿入機構
|
AU2018220538B2
(en)
|
2017-02-17 |
2023-12-14 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
JP2020508803A
(ja)
|
2017-03-06 |
2020-03-26 |
アムジエン・インコーポレーテツド |
作動防止特徴部を備える薬物送達デバイス
|
KR102627069B1
(ko)
|
2017-03-07 |
2024-01-18 |
암겐 인코포레이티드 |
과압에 의한 바늘 삽입
|
JP2020509837A
(ja)
|
2017-03-09 |
2020-04-02 |
アムジエン・インコーポレーテツド |
薬剤送達装置のための挿入機構
|
LT3600491T
(lt)
|
2017-03-28 |
2023-10-10 |
Amgen Inc. |
Stūmoklio koto ir švirkšto konstrukcinė sistema ir būdas
|
US11278505B2
(en)
|
2017-04-24 |
2022-03-22 |
University Of Massachusetts |
Diagnosis and treatment of vitiligo
|
EP3615069A1
(en)
|
2017-04-28 |
2020-03-04 |
Amgen Inc. |
N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
|
US11590294B2
(en)
|
2017-06-08 |
2023-02-28 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
MX2019014615A
(es)
|
2017-06-08 |
2020-02-07 |
Amgen Inc |
Dispositivo de administracion de farmacos accionado por par de torsion.
|
EP3641857A1
(en)
|
2017-06-22 |
2020-04-29 |
Amgen Inc. |
Device activation impact/shock reduction
|
EP3641861A1
(en)
|
2017-06-23 |
2020-04-29 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
JP7408398B2
(ja)
|
2017-07-14 |
2024-01-05 |
アムジエン・インコーポレーテツド |
二重ねじりばねシステムを有する針挿入後退システム
|
IL271173B2
(en)
|
2017-07-21 |
2024-04-01 |
Amgen Inc |
Gas permeable sealing element for drug container and methods of assembly
|
WO2019022950A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF
|
JP2020528296A
(ja)
|
2017-07-25 |
2020-09-24 |
アムジエン・インコーポレーテツド |
ギヤモジュールを有する薬物送達デバイス及び関連する組立方法
|
EP3662287B1
(en)
|
2017-08-01 |
2024-02-28 |
Amgen Inc. |
Systems and methods for real time preparation of a polypeptide sample for anaylsis with mass spectrometry
|
WO2019028191A1
(en)
|
2017-08-01 |
2019-02-07 |
Amgen Inc. |
SYSTEMS AND METHODS FOR PERFORMING REAL-TIME GLYCAN ASSAY OF A SAMPLE
|
EP3664863A2
(en)
|
2017-08-09 |
2020-06-17 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
EP3668567A1
(en)
|
2017-08-18 |
2020-06-24 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
EP4257164A3
(en)
|
2017-10-06 |
2024-01-17 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
MA50348A
(fr)
|
2017-10-09 |
2020-08-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
|
WO2019090086A1
(en)
|
2017-11-03 |
2019-05-09 |
Amgen Inc. |
Systems and approaches for sterilizing a drug delivery device
|
US20200338271A1
(en)
|
2017-11-06 |
2020-10-29 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
EP3706830A1
(en)
|
2017-11-06 |
2020-09-16 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
CN111225696B
(zh)
|
2017-11-10 |
2023-07-18 |
安进公司 |
用于药物递送装置的柱塞
|
SG11202003004RA
(en)
|
2017-11-16 |
2020-04-29 |
Amgen Inc |
Door latch mechanism for drug delivery device
|
MX2020005066A
(es)
|
2017-11-16 |
2020-08-20 |
Amgen Inc |
Autoinyector con deteccion de detencion y punto final.
|
WO2019143753A1
(en)
|
2018-01-17 |
2019-07-25 |
Amgen Inc. |
Drug delivery mechanism
|
US11744950B2
(en)
|
2018-03-07 |
2023-09-05 |
Amgen Inc. |
Controlled dispense syringe
|
EP3762067A1
(en)
|
2018-03-09 |
2021-01-13 |
Amgen Inc. |
Backflow prevention mechanism for drug delivery device
|
CA3093699A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
|
KR20200131266A
(ko)
|
2018-03-13 |
2020-11-23 |
암젠 인크 |
질량 분광 분석을 위한 폴리펩티드의 순차적 소화
|
SG11202007756XA
(en)
|
2018-03-30 |
2020-09-29 |
Amgen Inc |
Camera-based drug container inspection
|
US11583633B2
(en)
|
2018-04-03 |
2023-02-21 |
Amgen Inc. |
Systems and methods for delayed drug delivery
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
EP3810653A1
(en)
|
2018-06-23 |
2021-04-28 |
F. Hoffmann-La Roche AG |
Methods of treating lung cancer with a pd-1 axis binding antagonist, a platinum agent, and a topoisomerase ii inhibitor
|
CN112839644A
(zh)
|
2018-07-18 |
2021-05-25 |
豪夫迈·罗氏有限公司 |
用pd-1轴结合拮抗剂、抗代谢物和铂剂治疗肺癌的方法
|
US20210260279A1
(en)
|
2018-07-24 |
2021-08-26 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
US20210128844A1
(en)
|
2018-07-24 |
2021-05-06 |
Amgen Inc. |
Delivery devices for administering drugs
|
WO2020023444A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
CA3103105A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
TW202019478A
(zh)
|
2018-08-08 |
2020-06-01 |
美商建南德克公司 |
色胺酸衍生物及l-甲硫胺酸用於蛋白質調配之用途
|
MA53227A
(fr)
|
2018-08-17 |
2021-11-24 |
Amgen Inc |
Mécanisme d'activation pour dispositif d'administration de médicament
|
PL3857230T3
(pl)
|
2018-09-21 |
2023-10-16 |
F. Hoffmann-La Roche Ag |
Sposoby diagnostyczne dla potrójnie ujemnego raka piersi
|
AU2019347710A1
(en)
|
2018-09-24 |
2021-02-04 |
Amgen Inc. |
Interventional dosing systems and methods
|
EP3856283A1
(en)
|
2018-09-28 |
2021-08-04 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
WO2020072577A1
(en)
|
2018-10-02 |
2020-04-09 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
MA53818A
(fr)
|
2018-10-05 |
2022-01-12 |
Amgen Inc |
Dispositif d'administration de médicament ayant un indicateur de dose
|
EA202191037A1
(ru)
|
2018-10-15 |
2021-08-05 |
Эмджен Инк. |
Устройство доставки лекарственного средства, имеющее демпферный механизм
|
EP3866889A1
(en)
|
2018-10-15 |
2021-08-25 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
US20220031939A1
(en)
|
2018-11-01 |
2022-02-03 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
MA54048A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament avec rétraction partielle de l'organe d'administration de médicament
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
WO2020124008A1
(en)
|
2018-12-14 |
2020-06-18 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
US11534547B2
(en)
|
2019-01-24 |
2022-12-27 |
Amgen Inc. |
Drug delivery systems and methods with pressure sensitive control
|
EP3914320A1
(en)
|
2019-01-24 |
2021-12-01 |
Amgen Inc. |
Drug delivery systems and methods with back pressure sensing
|
EP3924016A1
(en)
|
2019-02-12 |
2021-12-22 |
Amgen Inc. |
Continuous dosing systems and approaches
|
EP3924018A1
(en)
|
2019-02-12 |
2021-12-22 |
Amgen Inc. |
Continuous dosing systems and approaches
|
US20200254173A1
(en)
|
2019-02-12 |
2020-08-13 |
Amgen Inc. |
Take-home drug delivery system
|
EP3923896A1
(en)
|
2019-02-12 |
2021-12-22 |
Amgen Inc. |
Systems and approaches for drug delivery device reconstitution
|
US20220062543A1
(en)
|
2019-02-12 |
2022-03-03 |
Amgen Inc. |
Continuous dosing systems and approaches
|
EP3924015A1
(en)
|
2019-02-12 |
2021-12-22 |
Amgen Inc. |
Dosing systems and approaches
|
CA3128233A1
(en)
|
2019-02-14 |
2020-08-20 |
Amgen Inc. |
Systems and methods for preparing a sample and performing a real-time assay of the sample
|
US20220137010A1
(en)
|
2019-02-20 |
2022-05-05 |
Amgen Inc. |
Methods of determining protein stability
|
US20230035363A1
(en)
|
2019-03-04 |
2023-02-02 |
Amgen Inc. |
In vivo reversibility of high molecular weight species
|
US20220187398A1
(en)
|
2019-03-27 |
2022-06-16 |
Amgen Inc. |
Methods of fingerprinting therapeutic proteins via a two-dimensional (2d) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
|
EP3952950A1
(en)
|
2019-04-08 |
2022-02-16 |
Amgen Inc. |
Automated drug delivery device and container
|
WO2020210142A1
(en)
|
2019-04-09 |
2020-10-15 |
Amgen Inc. |
Drug delivery device with smart grip
|
US20220184318A1
(en)
|
2019-04-17 |
2022-06-16 |
Amgen Inc. |
Cassette for an autoinjector and related methods
|
AU2020263289A1
(en)
|
2019-04-24 |
2021-09-16 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
WO2020219672A1
(en)
|
2019-04-24 |
2020-10-29 |
Amgen Inc. |
Injector accessories
|
MX2021014733A
(es)
|
2019-06-05 |
2022-04-06 |
Amgen Inc |
Metodos de identificacion de atributos de proteinas terapeuticas.
|
EP3983432A1
(en)
|
2019-06-12 |
2022-04-20 |
Askgene Pharma, Inc. |
Novel il-15 prodrugs and methods of use thereof
|
AU2020298084A1
(en)
|
2019-06-20 |
2021-11-04 |
Amgen Inc. |
Wireless communication enabled drug delivery device and method
|
WO2021011716A1
(en)
|
2019-07-18 |
2021-01-21 |
Amgen Inc. |
Drug delivery device having pressurized vessel
|
US20220249778A1
(en)
|
2019-07-18 |
2022-08-11 |
Amgen Inc. |
Sealing arrangement for drug delivery device
|
JP2022542290A
(ja)
|
2019-08-01 |
2022-09-30 |
アムジエン・インコーポレーテツド |
温度測定を備えた薬物送達デバイス及び関連方法
|
EP4017560A2
(en)
|
2019-08-23 |
2022-06-29 |
Amgen, Inc |
Drug delivery device with configurable needle shield engagement components and related methods
|
AU2020340905A1
(en)
|
2019-09-03 |
2022-03-10 |
Amgen Inc. |
Activatable injection device for drug delivery
|
US20210060258A1
(en)
|
2019-09-03 |
2021-03-04 |
Amgen Inc. |
Injection device for drug delivery and packaging for the injection device
|
US20220362462A1
(en)
|
2019-09-12 |
2022-11-17 |
Amgen Inc. |
Backflow Prevention Mechanism for Drug Delivery Device
|
MX2022002980A
(es)
|
2019-09-16 |
2022-04-06 |
Amgen Inc |
Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos.
|
WO2021067990A1
(en)
|
2019-09-30 |
2021-04-08 |
Amgen Inc. |
Drug delivery device
|
BR112022005850A2
(pt)
|
2019-09-30 |
2022-06-21 |
Amgen Inc |
Dispositivo de administração de fármaco
|
WO2021067989A1
(en)
|
2019-09-30 |
2021-04-08 |
Amgen Inc. |
Drug delivery device
|
MX2022003292A
(es)
|
2019-09-30 |
2022-04-12 |
Amgen Inc |
Dispositivo de administracion de farmacos y metodos de administracion de un farmaco.
|
MX2022003700A
(es)
|
2019-09-30 |
2022-04-26 |
Amgen Inc |
Dispositivo de administracion de farmacos.
|
CA3151476A1
(en)
|
2019-09-30 |
2021-04-08 |
Amgen Inc. |
Drug delivery device
|
US20220340326A1
(en)
|
2019-10-07 |
2022-10-27 |
Amgen Inc. |
Packages for pharmaceutical products and methods of assembly
|
EP4041342A1
(en)
|
2019-10-07 |
2022-08-17 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
US11660435B2
(en)
|
2019-10-07 |
2023-05-30 |
Amgen Inc. |
Light-activated ultrasonic delivery and manipulation of liquid medication from a drug reservoir
|
EP4041347A1
(en)
|
2019-10-07 |
2022-08-17 |
Amgen Inc. |
Drug delivery device with fingerprint sensor
|
EP4041341A1
(en)
|
2019-10-08 |
2022-08-17 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
WO2021071917A1
(en)
|
2019-10-08 |
2021-04-15 |
Amgen Inc. |
Cassette for an autoinjector and related methods
|
WO2021071886A1
(en)
|
2019-10-08 |
2021-04-15 |
Amgen Inc. |
Drug delivery device
|
EP4041344A1
(en)
|
2019-10-08 |
2022-08-17 |
Amgen Inc. |
Temperature indicator for drug delivery device
|
US20240066215A1
(en)
|
2019-10-18 |
2024-02-29 |
Amgen Inc. |
Drug delivery device and system
|
EP4045110A2
(en)
|
2019-10-18 |
2022-08-24 |
Amgen Inc. |
Drug delivery device and system
|
JP2022551738A
(ja)
|
2019-10-18 |
2022-12-13 |
アムジエン・インコーポレーテツド |
薬物送達デバイス再構成のためのシステム及び手法
|
JP2022551737A
(ja)
|
2019-10-18 |
2022-12-13 |
アムジエン・インコーポレーテツド |
薬物送達デバイス再構成のためのシステム及び手法
|
US20220401643A1
(en)
|
2019-10-21 |
2022-12-22 |
Amgen Inc. |
Drug product container and drug delivery system
|
JP2022553316A
(ja)
|
2019-10-24 |
2022-12-22 |
アムジエン・インコーポレーテツド |
薬物送達のためのシステム及び手法
|
WO2021081161A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Systems and components for drug delivery and components for preparation of the same
|
WO2021080822A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Systems and methods for drug delivery
|
EP4048345A1
(en)
|
2019-10-24 |
2022-08-31 |
Amgen, Inc |
Drug delivery device and system
|
WO2021081283A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Drug delivery device
|
EP4054673A1
(en)
|
2019-11-07 |
2022-09-14 |
Amgen Inc. |
Drug delivery system and method of use
|
EP4069340A1
(en)
|
2019-12-02 |
2022-10-12 |
Amgen Inc. |
Lockout mechanism for drug delivery device
|
WO2021113070A1
(en)
|
2019-12-05 |
2021-06-10 |
Amgen Inc, |
Flow restrictor for drug delivery device
|
CA3165927A1
(en)
|
2020-01-11 |
2021-07-15 |
AskGene Pharma, Inc. |
Novel masked cytokines and methods of use thereof
|
JP2023510310A
(ja)
|
2020-01-13 |
2023-03-13 |
アムジエン・インコーポレーテツド |
ニードルシールドリムーバ、薬物送達デバイス、及び関連する方法
|
MX2022010177A
(es)
|
2020-02-24 |
2022-09-12 |
Amgen Inc |
Envases y sistemas para su uso durante la esterilizacion externa de dispositivos de administracion de farmacos.
|
WO2021188223A1
(en)
|
2020-03-16 |
2021-09-23 |
Amgen Inc. |
Drug delivery member insertion sensing assemblies, drug delivery devices, and related methods
|
AU2021237233A1
(en)
|
2020-03-17 |
2022-08-25 |
Amgen Inc. |
Controlled dispense syringe
|
EP4143811A1
(en)
|
2020-04-28 |
2023-03-08 |
Amgen Inc. |
Packaging label
|
WO2021236477A1
(en)
|
2020-05-22 |
2021-11-25 |
Amgen Inc. |
Storage system and method for storing and transporting medicament
|
MX2022015877A
(es)
|
2020-06-16 |
2023-01-24 |
Genentech Inc |
Metodos y composiciones para tratar cancer de mama triple negativo.
|
CN116096648A
(zh)
|
2020-09-02 |
2023-05-09 |
美国安进公司 |
用于药剂储存纸盒的易打开设备
|
WO2022055779A1
(en)
|
2020-09-09 |
2022-03-17 |
Amgen Inc. |
Swallowable drug delivery devices
|
WO2022055761A1
(en)
|
2020-09-11 |
2022-03-17 |
Amgen Inc. |
Inline uv flow device for sterilizing flow cytometry sheath fluid
|
CA3195365A1
(en)
|
2020-09-18 |
2022-03-24 |
Amgen Inc. |
Methods of processing a sample for peptide mapping analysis
|
CA3192737A1
(en)
|
2020-10-12 |
2022-04-21 |
Amgen Inc. |
Long-term medicament storage apparatus and methods
|
CA3196039A1
(en)
|
2020-11-04 |
2022-05-12 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
US20230381423A1
(en)
|
2020-11-04 |
2023-11-30 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
US20230381426A1
(en)
|
2020-11-04 |
2023-11-30 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
WO2022098593A1
(en)
|
2020-11-04 |
2022-05-12 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
WO2022098595A1
(en)
|
2020-11-05 |
2022-05-12 |
Amgen Inc. |
Materials and methods for protein processing
|
US20240082110A1
(en)
|
2021-02-03 |
2024-03-14 |
Amgen Inc. |
Coaxial needle adapter and guide bracket for robotic liquid handling platform
|
CN116782993A
(zh)
|
2021-02-03 |
2023-09-19 |
美国安进公司 |
用于药物加工的系统和方法
|
EP4288198A1
(en)
|
2021-02-03 |
2023-12-13 |
Amgen Inc. |
High-throughput automated reconstitution of lyophilized drug product
|
CN116940393A
(zh)
|
2021-03-08 |
2023-10-24 |
美国安进公司 |
中空柱塞杆的制造工艺
|
CA3211430A1
(en)
|
2021-03-10 |
2022-09-15 |
Amgen Inc. |
Drug delivery device having removable cap
|
JP2024508951A
(ja)
|
2021-03-10 |
2024-02-28 |
アムジエン・インコーポレーテツド |
薬物送達デバイス、薬物送達デバイス用のサブアセンブリ、シリンジホルダ、及び組立方法
|
JP2024509234A
(ja)
|
2021-03-10 |
2024-02-29 |
アムジエン・インコーポレーテツド |
薬物送達デバイス
|
EP4313213A1
(en)
|
2021-03-25 |
2024-02-07 |
Amgen Inc. |
Drug delivery device
|
US20240157057A1
(en)
|
2021-03-31 |
2024-05-16 |
Amgen Inc. |
Sound-detection based injection time measurement system for drug delivery devices
|
JP2024516113A
(ja)
|
2021-04-22 |
2024-04-12 |
アムジエン・インコーポレーテツド |
自動化シリンジ品質評価のための方法及びシステム
|
CA3213303A1
(en)
|
2021-04-28 |
2022-11-03 |
Amgen Inc. |
Systems for out-patient treatment of a patient, and related methods
|
EP4341945A1
(en)
|
2021-05-17 |
2024-03-27 |
Amgen Inc. |
Feedback system and method for a drug product
|
AU2022279223A1
(en)
|
2021-05-21 |
2023-10-19 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
WO2022256199A1
(en)
|
2021-06-01 |
2022-12-08 |
Amgen Inc. |
Lyophilization system
|
AU2022288864A1
(en)
|
2021-06-08 |
2023-10-19 |
Amgen Inc. |
Drug delivery devices, finger-grip elements, and related methods
|
BR112023026548A2
(pt)
|
2021-06-17 |
2024-03-05 |
Amgen Inc |
Dispositivo de administração de fármacos tendo amortecedor
|
CN117545519A
(zh)
|
2021-06-23 |
2024-02-09 |
美国安进公司 |
注射器、组件和制造方法
|
WO2023278125A1
(en)
|
2021-06-28 |
2023-01-05 |
Amgen Inc. |
Safety device for drug delivery system
|
WO2023287562A1
(en)
|
2021-07-16 |
2023-01-19 |
Amgen Inc. |
Systems and approaches for drug processing single-use hardware
|
AU2022356197A1
(en)
|
2021-09-29 |
2024-02-08 |
Amgen Inc. |
Apparatuses, systems and methods for plunger-stopper depth measurement in pre-filled syringes
|
WO2023059671A1
(en)
|
2021-10-06 |
2023-04-13 |
Amgen Inc. |
Impact activated retention feature for drug delivery device
|
IL311228A
(en)
|
2021-10-06 |
2024-05-01 |
Amgen Inc |
An impact-activated braking feature for a drug delivery device
|
AU2022366707A1
(en)
|
2021-10-11 |
2024-03-14 |
Amgen Inc. |
Characterization apparatus for drug delivery devices or subcomponents thereof
|
AU2022382741A1
(en)
|
2021-11-05 |
2024-04-04 |
Amgen Inc. |
Drug delivery devices, components for use within drug delivery devices
|
AU2022388727A1
(en)
|
2021-11-09 |
2024-05-16 |
Amgen Inc. |
Production of therapeutic proteins
|
WO2023097069A1
(en)
|
2021-11-29 |
2023-06-01 |
Amgen Inc. |
Plunger rod removal force method and fixture
|
TW202335692A
(zh)
|
2021-12-03 |
2023-09-16 |
美商安進公司 |
注射器中的塞子放置
|
WO2023172592A1
(en)
|
2022-03-11 |
2023-09-14 |
Amgen Inc. |
Adjustable depth autoinjector
|
WO2023196111A1
(en)
|
2022-04-06 |
2023-10-12 |
Amgen Inc. |
Packaging for drug delivery device
|
WO2024028448A1
(en)
|
2022-08-04 |
2024-02-08 |
Calypso Biotech Sa |
Il-15 inhibitors useful for the treatment of atopic dermatitis
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|
WO2024039707A1
(en)
|
2022-08-18 |
2024-02-22 |
Amgen Inc. |
Needle shield assembly for a syringe
|
WO2024039575A1
(en)
|
2022-08-18 |
2024-02-22 |
Amgen Inc. |
Needle shield for syringe
|
WO2024049793A1
(en)
|
2022-08-30 |
2024-03-07 |
Amgen Inc. |
System and method of limiting subvisible particles in a syringe
|
CN117209605B
(zh)
*
|
2023-11-09 |
2024-01-30 |
北京百普赛斯生物科技股份有限公司 |
特异性结合il-15的抗体及其应用
|